The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors)

Transfusion

Volumn 57, Issue 10, 2017, Pages 2440-2448

  Cable, Ritchard G ^a   Birch, Rebecca J ^b   Spencer, Bryan R ^a   Wright, David J ^b   Bialkowski, Walter ^c   Kiss, Joseph E ^d   Rios, Jorge ^a   Bryant, Barbara J ^c,e   Mast, Alan E ^c,f  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b WESTAT   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

^d INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; PLACEBO; IRON;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; HUMAN; IRON DEFICIENCY; IRON THERAPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; BLOOD; DIETARY SUPPLEMENT; INFORMATION DISSEMINATION; PROTOCOL COMPLIANCE; PSYCHOLOGY; WRITING;

BLOOD DONORS; CORRESPONDENCE AS TOPIC; DIETARY SUPPLEMENTS; FERRITINS; GUIDELINE ADHERENCE; HEMOGLOBINS; HUMANS; INFORMATION DISSEMINATION; IRON;

EID: 85029788709     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14226     Document Type: Article

References (22)

1. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2012;52:702-11.
2. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion 2011;51:511-22.
3. Delaney M, Schellhase KG, Young S, Geiger S, Fink A, Mast AE. Blood center practice and education for blood donors with anemia. Transfusion 2011;51:929-36.
4. Kiss JE, Brambilla D, Glynn SA, et al. Oral iron supplementation after blood donation: a randomized clinical trial. JAMA 2015;6:575-83.
5. O'Brien SF. Donor iron policy: from research to practice. Transfusion 2016;56:1496-8.
6. O'Meara A, Infanti L, Stebler C, et al. The value of routine ferritin measurement in blood donors. Transfusion 2011;51:2183-8.
7. Spencer BR, Johnson B, Wright DJ, et al. Potential impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals. Transfusion 2016;56:1994-2004.
8. Bialkowski W, Bryant BJ, Schlumpf KS, et al. The strategies to reduce iron deficiency in blood donors randomized trial: design, enrolment and early retention. Vox Sang 2015;108:178-85.
9. Mast AE, Bialkowski W, Bryant BJ, et al. A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion 2016;56:1588-97.
10. Chansky MC, King MR, Bialkowski W, et al. Qualitative assessment of pica experienced by frequent blood donors. Transfusion 2017;57:946-51.
11. Center for Biologics Evaluation and Research, US Food and Drug Administration. Blood Products Advisory Committee, September 10, 2008 [cited 2017 Jun 20]. Available from: https://www.fda.gov/ohrms/dockets/ac/08/transcripts/2008-4379T1_3.htm.
12. Center for Biologics Evaluation and Research, US Food and Drug Administration. Blood Products Advisory Committee, July 27, 2010 [cited 2017 Jun 20]. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM225389.pdf.
13. Center for Biologics Evaluation and Research, US Food and Drug Administration. Blood Products Advisory Committee, November 17, 2016 [cited 2017 Jun 20]. Available from: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/ucm501664.htm.
14. US Food and Drug Administration. Hemoglobin standards and maintaining adequate iron stores in blood donors. Public workshop, November 9, 2011 [cited 2017 Jun 20]. Available from: https://wayback.archive-it.org/7993/20170112100421/http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm268757.htm.
15. Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev 2014;7:CD009532.
16. White LK, Harris VJ, Cruz JL, Waxman DA. How do we design, implement, and manage an ongoing program to provide iron supplements to women blood donors?. Transfusion 2014;54:2795-801.
17. Cable RG, Spencer BR, Steele WR 3rd, Mast AE. Self-reported iron supplement use in blood donors. Transfusion 2011;51(suppl):96A-7A.
18. Steele WR, Notari EP, Eder AF. Iron supplement use and iron deficiency awareness among active donors: baseline survey results. Transfusion 2013;53(suppl):105A.
19. Cable RG, Papallo CT, Spencer BR. Self-initiated iron supplementation (IS) in blood donors: demographics, patterns of use, and motivation. Transfusion 2016;56(suppl):98A.
20. Goldman M, Uzicanin S, Scalia J, Scalia V, O'Brien SF. Impact of informing donors of low ferritin results. Transfusion 2016;56:2193-8.
21. Goldman M, Uzicanin S, Osmond L, Scalia V, O'Brien SF. A large national study of ferritin testing in Canadian blood donors. Transfusion 2017;57:564-70.
22. Magnussen K, Ladelund S. Handling low hemoglobin and iron deficiency in a blood donor population: 2 years' experience. Transfusion 2015;55:2473-8.